Short-term [tmco]
Effect [qlco]
tibolone [phsu, strd]
C-reactive protein [aapp, imft]
hypertensive [fndg]
postmenopausal [tmco]
Women [popg]
To [qlco]
Evaluate [ftcn]
effects [qlco]
tibolone [phsu, strd]
Serum [bdsu]
C-reactive protein [aapp, imft]
hypertensive [fndg]
postmenopausal [tmco]
Women [popg]
postmenopausal [tmco]
Patients [podg]
Hypertension [dsyn]
Normotensive [fndg]
postmenopausal [tmco]
Women [popg]
Inclusion Criteria [qlco]
Surgical menopause [dsyn]
Presence [topp]
vasomotor symptom [sosy]
Normal [qlco]
Mammogram [diap]
absence [qnco]
Documented [hlca]
coronary artery disease [dsyn]
Normal [qlco]
electrocardiography [fndg]
hypertensive [fndg]
Women [popg]
Normotensive [fndg]
Women [popg]
COMPLETED [qlco]
month [tmco]
twenty [orch, phsu]
One [qnco]
hypertensive [fndg]
Women [popg]
Received [qlco]
tibolone [phsu, strd]
Control [grup]
baseline [bodm]
blood lipids [lipd]
C-reactive protein [aapp, imft]
Evaluated [ftcn]
Lipid [lipd]
Profile [lbpr]
C-reactive protein [aapp, imft]
hypertensive [fndg]
Normotensive [fndg]
Control Groups [grup]
Not significant [fndg]
Statistically [ocdi]
Total Cholesterol [lbpr]
Level [qlco]
Decreased [qnco]
tibolone [phsu, strd]
treatment [ftcn]
Increase [ftcn]
C-reactive protein [aapp, imft]
Values [qlco]
Observed [ftcn]
tibolone [phsu, strd]
Group [idcn]
P NOS [aapp, imft]
This [euka]
Trial [resa]
tibolone [phsu, strd]
treatment [ftcn]
Induced [ftcn]
Increase [ftcn]
C-reactive protein [aapp, imft]
Decrease [qlco]
Total Cholesterol [lbpr]
postmenopausal [tmco]
hypertensive [fndg]
Women [popg]
